Press Releases

Amicus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 3, 2023 at 7:01 AM EST

PHILADELPHIA, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that Bradley Campbell, President and Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 9, 2023 at 2:15 p.m. PT.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at, and follow on Twitter and LinkedIn.


Amicus Therapeutics
Andrew Faughnan
Executive Director, Investor Relations
(609) 662-3809

Amicus Therapeutics
Diana Moore
Head of Global Communications
(609) 662-5079